Lorrain Daniel S.

Lorrain Daniel S. is listed in filings as Chief Scientific Officer at Contineum Therapeutics, Inc. Class A Common Stock. This profile follows SEC Form 4 activity through Jun 1, 2026, including sale activity. Recent filings connect the profile to Contineum Therapeutics, Inc. Class A Common Stock (CTNM). The current snapshot covers public activity from Nov 20, 2024 to Jun 1, 2026. Reported amounts are shown as $54.9K to $50.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.